Supernus Pharmaceuticals Inc (SUPN)
29.98
+0.27
(+0.91%)
USD |
NASDAQ |
Apr 23, 16:00
29.95
-0.03
(-0.10%)
After-Hours: 20:00
Supernus Pharmaceuticals Market Cap: 1.641B for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 1.641B |
| April 22, 2024 | 1.626B |
| April 19, 2024 | 1.609B |
| April 18, 2024 | 1.580B |
| April 17, 2024 | 1.587B |
| April 16, 2024 | 1.611B |
| April 15, 2024 | 1.642B |
| April 12, 2024 | 1.655B |
| April 11, 2024 | 1.752B |
| April 10, 2024 | 1.743B |
| April 09, 2024 | 1.737B |
| April 08, 2024 | 1.720B |
| April 05, 2024 | 1.836B |
| April 04, 2024 | 1.819B |
| April 03, 2024 | 1.853B |
| April 02, 2024 | 1.816B |
| April 01, 2024 | 1.835B |
| March 28, 2024 | 1.867B |
| March 27, 2024 | 1.847B |
| March 26, 2024 | 1.778B |
| March 25, 2024 | 1.793B |
| March 22, 2024 | 1.889B |
| March 21, 2024 | 1.925B |
| March 20, 2024 | 1.909B |
| March 19, 2024 | 1.924B |
| Date | Value |
|---|---|
| March 18, 2024 | 1.871B |
| March 15, 2024 | 1.805B |
| March 14, 2024 | 1.827B |
| March 13, 2024 | 1.897B |
| March 12, 2024 | 1.802B |
| March 11, 2024 | 1.775B |
| March 08, 2024 | 1.701B |
| March 07, 2024 | 1.686B |
| March 06, 2024 | 1.703B |
| March 05, 2024 | 1.661B |
| March 04, 2024 | 1.677B |
| March 01, 2024 | 1.697B |
| February 29, 2024 | 1.626B |
| February 28, 2024 | 1.701B |
| February 27, 2024 | 1.680B |
| February 26, 2024 | 1.615B |
| February 23, 2024 | 1.591B |
| February 22, 2024 | 1.529B |
| February 21, 2024 | 1.540B |
| February 20, 2024 | 1.535B |
| February 16, 2024 | 1.555B |
| February 15, 2024 | 1.568B |
| February 14, 2024 | 1.508B |
| February 13, 2024 | 1.484B |
| February 12, 2024 | 1.551B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
759.12M
Minimum
Mar 18 2020
2.280B
Maximum
Feb 02 2023
1.540B
Average
1.557B
Median
Feb 25 2021
Market Cap Benchmarks
| Dynavax Technologies Corp | 1.536B |
| Ligand Pharmaceuticals Inc | 1.237B |
| Pacira BioSciences Inc | 1.247B |
| Esperion Therapeutics Inc | 386.76M |
| Collegium Pharmaceutical Inc | 1.149B |
Market Cap Related Metrics
| PS Ratio | 2.799 |
| Price to Book Value | 1.781 |
| Price to Free Cash Flow | 15.38 |
| Price | 29.98 |
| Earnings Yield | -0.01% |
| Operating PE Ratio | 126.87 |
| Normalized PE Ratio | 112.32 |